In the analysis of human database, we found that S100A9 expression level was positively correlated with human breast cancer development stages (Supplementary Fig. 2e) and Pearson correlation analysis revealed a negative correlation between BRCA1 and S100A9 in breast cancer patients (Supplementary Fig. 2f). Here, S100A9 is linked to breast carcinoma.